Crossref
First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds
JAMA · 28.07.2026 · 336 (4) · 273
DOI: 10.1001/jama.2026.12326 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 28.07.2026. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News, JAMA.
Themen: Demenz
Abstract (Originalsprache)
This Medical News article discusses a recent study in JAMA Neurology about the real-world use of the first approved plasma test for biomarkers of Alzheimer disease pathology.
Autor:innen und Institutionen
- Lead Senior Staff Writer, Medical News, JAMA.
Zitieren
APA
Rubin, R. (2026). First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds. JAMA, 336(4), 273. https://doi.org/10.1001/jama.2026.12326
Vancouver
Rubin R. First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds. JAMA. 2026;336(4):273. doi:10.1001/jama.2026.12326
BibTeX
@article{Rubin2026,
author = {Rubin, Rita},
title = {First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds},
journal = {JAMA},
year = {2026},
volume = {336},
number = {4},
pages = {273},
doi = {10.1001/jama.2026.12326}
}
EUVIMED